Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
6.8% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
8
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
2.0% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
12
users have liked this narrative
2
users have commented on this narrative
18
users have followed this narrative
8 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.9% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
15
users have liked this narrative
4
users have commented on this narrative
16
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
2
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Target
AN
AnalystLowTarget
Consensus Narrative from 32 Analysts
Retail Infrastructure And AI Will Modernize Future Operations Despite Risks
Key Takeaways Strategic investments aim to enhance operational efficiency and boost revenue by modernizing stores, supply chain, and technology. Focus on loyalty programs and technology modernization drives market share gains, customer engagement, and improved profitability.
View narrative
US$82.00
FV
28.5% overvalued
intrinsic discount
0.61%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
PayPal Holdings
AN
AnalystLowTarget
Consensus Narrative from 33 Analysts
Central Bank Digital Currencies Will Jeopardize Payment Revenues
Key Takeaways Rising competition from fintech, big tech, and alternative payment technologies is threatening PayPal's core business and long-term revenue growth. Regulatory pressures and the shift toward integrated super-apps and digital currencies are increasing costs and eroding user acquisition and retention.
View narrative
US$62.00
FV
11.4% overvalued
intrinsic discount
4.40%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
4 days ago
author updated this narrative
Arm Holdings
AN
AnalystLowTarget
Consensus Narrative from 33 Analysts
In-house Chip Design And RISC-V Will Undermine Licensing Revenue
Key Takeaways Rising in-house chip design by key clients and open-source adoption threaten Arm's traditional licensing and royalty-based revenue streams. Increased R&D spending and changing market dynamics could squeeze margins, while geopolitical tensions risk limiting access to critical growth markets.
View narrative
US$85.95
FV
55.9% overvalued
intrinsic discount
15.88%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
4 days ago
author updated this narrative
Arista Networks
AN
AnalystLowTarget
Consensus Narrative from 24 Analysts
Reliance On Hyperscale Customers And Rising Pressures Will Undermine Prospects
Key Takeaways Heavy dependence on large cloud and AI customers, shifting industry technology, and hyperscaler in-house hardware pose risks to revenue stability and margin resilience. Global protectionism, sustainability pressures, and intensifying competition may increase costs, limit market expansion, and compress future profitability.
View narrative
US$106.82
FV
24.3% overvalued
intrinsic discount
14.63%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
4 days ago
author updated this narrative
Airbnb
AN
AnalystLowTarget
Consensus Narrative from 35 Analysts
Rising Regulatory Hurdles And Market Saturation Will Bar Recovery
Key Takeaways Regulatory headwinds, negative public sentiment, and housing market criticisms threaten Airbnb's growth prospects and restrict market expansion. Rising competition, compliance costs, and market saturation erode profit margins and challenge efforts to sustain revenue growth.
View narrative
US$99.00
FV
27.3% overvalued
intrinsic discount
8.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
4 days ago
author updated this narrative
Regeneron Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 23 Analysts
US Healthcare Reforms And Biosimilars Will Erode Margins
Key Takeaways Reliance on a few key products and increasing biosimilar competition threaten revenue growth and earnings stability as healthcare reforms pressure pricing power. Rising R&D expenses and demographic headwinds may limit the long-term growth potential and sustainability of current revenue streams.
View narrative
US$543.00
FV
5.3% overvalued
intrinsic discount
1.19%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
4 days ago
author updated this narrative
Bristol-Myers Squibb
AN
AnalystLowTarget
Consensus Narrative from 21 Analysts
Debt And Patent Expiries Will Erode US Pharma Margins
Key Takeaways Loss of exclusivity and pricing pressures will erode revenue and margin growth, posing significant long-term financial headwinds. High debt, execution risk, and tougher regulatory climate restrict flexibility, increase costs, and threaten sustainable profitability.
View narrative
US$35.86
FV
34.8% overvalued
intrinsic discount
-6.24%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
4 days ago
author updated this narrative
NextEra Energy
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Rising Costs And Fading Credits Will Hamper Outlook Despite Demand
Key Takeaways Expiring renewables tax credits, higher interest rates, and regulatory hurdles threaten project returns, earnings growth, and consistent revenue conversion for NextEra Energy. Rising adoption of distributed energy resources and high debt levels risk eroding traditional revenue streams and put pressure on credit quality and dividend growth expectations.
View narrative
US$59.28
FV
29.1% overvalued
intrinsic discount
9.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Vertex Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 25 Analysts
Regulatory Scrutiny And High Costs Will Hinder Gene Therapy Progress
Key Takeaways Intensifying regulatory pressures and high treatment costs threaten Vertex's pricing power and market expansion, leading to margin compression and limited revenue growth. Heavy R&D demands, a narrowly focused pipeline, and rising competition increase earnings volatility and risk significant erosion of market share and profitability.
View narrative
US$347.89
FV
12.3% overvalued
intrinsic discount
2.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
4 days ago
author updated this narrative
Value any company in seconds
Popular companies